molecules that result from the replication of those described in (1) above. Synthetic DNA segments that are likely to yield a potentially harmful polynucleotide or polypeptide (e.g., a toxin or a ...

This webinar will be hosted live and available on-demand Thursday, June 5th, 2025 10:00 - 11:00 AM ET From protein translation to mitosis, fundamental cellular processes are multifaceted and dynamic.

Recombinant antibody engineering affords researchers and drug developers a wide range of opportunities for creating unique molecules with attributes ideally suited to the treatment of specific ...

As well as offering a path through the immunology maze, the course will emphasize the R&D opportunities for therapeutic intervention that arise from recent advances in immunology, for example the use ...

MSA is a synucleinopathy that mostly affects glial cells. In his speech, Goedert noted that, as is the case for tau, human brain-derived structures are markedly different than those of recombinant ...

Last year, sales of the 10 top-selling drugs were split 40:60 between small molecules and larger, more complicated biologics, according to Drug Discovery and Development. But those numbers are ...